MedTrace Logo

S-FLEX Netherlands Registry: Prospective Evaluation of the Supraflex Family Sirolimus-eluting Coronary Stent System

NCT03443999 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2026-04-23

No results posted yet for this study

Summary

The primary objective of this registry is to evaluate the safety and efficacy of the Supraflex Family sirolimus-eluting coronary stent system in a 'real-world' patient population requiring stent implantation.

Conditions

Interventions

DEVICE

Supraflex Family Sirolimus-eluting Coronary Stent System

Patient implanted with at least one Supraflex Family sirolimus-eluting stent as a part of planned clinical care

Sponsors & Collaborators

  • Sahajanand Medical Technologies Limited

    lead INDUSTRY

Principal Investigators

  • Dr. A.J.J. IJsselmuiden, MD. · Amphia Hospital, Breda, The Netherlands

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-27
Primary Completion
2027-06-30
Completion
2027-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03443999 on ClinicalTrials.gov